Delivery Order SPE2DB22D3301-SPE2DB25FY0PN

Award Date 2/25/25
Potential Completion Date 3/18/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product, with a performance period through December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,955.43 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the supply of BOSULIF 100 MG TABLET 120S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $10,955.43, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 delivery order contract is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The firm-fixed-price Delivery Order, valued at $10,577.74, has a period of performance through November 25, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award, valued at $10,955.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with a ceiling value of $10,955.43, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a prescription medication, to support the healthcare needs of government agencies and programs. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, that...
This federal contract award, valued at $43,821.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,047.42, is to deliver 120 units of the prescription drug BOSULIF 100 mg tablets. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY0PN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order contract is for the supply of BOSULIF 400 MG TABLET 30S, a prescription drug, with a period of performance through March 18, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:48 AM